After AstraZeneca, America suspends the granting of Johnson & Johnson vaccine


America has suspended the granting of the Johnson & Johnson vaccine pending verification of reports that it causes strokes.

These developments come at a time when the European Medicines Authority announced last Friday that it is studying cases of blood clots after receiving Johnson & Johnson vaccine.

Similar cases of side effects were the most recent The AstraZeneca vaccine has led to the suspension of many countries vaccinating its use, and giving the second dose to those under 55 years using other vaccines, as France announced last week.

The World Health Organization has confirmed that it cannot in the absence of sufficient data Issuing a recommendation to change the anti-Covid vaccine between two doses, which France intends to do for those under the age of 55 who have received a first dose of AstraZeneca.

The Johnson & Johnson company had previously agreed, On the supply of up to 400 million vaccines against Corona to the African Union until the end of next year, giving a boost to a continent that lags behind most countries in the world in the race to vaccinate against the disease.

And to that, the pharmaceutical company can provide American has up to 220 million doses of Its single candidate is to 55 member states of the African Union starting in the third quarter of 2021.

The statement added that another 180 million could then be delivered in the following year, according to Bloomberg. Al

This agreement follows agreements with AstraZeneca, Pfizer and Sputnik in Russia.

The post After AstraZeneca, America suspends the granting of Johnson & Johnson vaccine appeared first on World Weekly News.